Search for: "GLAXOSMITHKLINE INC."
Results 21 - 40
of 355
Sorted by Relevance
|
Sort by Date
28 Mar 2010, 8:33 pm
Glaxosmithkline LLC et al. 3:10-cv-00608; filed March 24, 2010 in the Southern District of California • Plaintiffs: Biogen Idec, Inc.; Genentech, Inc. [read post]
15 Oct 2008, 1:00 pm
GlaxoSmithKline, Inc., ___ Cal.App.4th ___ (Sept. 19, 2008; mod. [read post]
20 Apr 2009, 9:41 am
GlaxoSmithKline plc and Stiefel Laboratories Inc. have turned to two law firms with longtime ties to the companies for the $2.9 billion deal the pharmaceutical companies announced Monday. [read post]
25 Nov 2014, 9:55 pm
• Defendants: Glaxosmithkline LLC; Aptalis Pharma US, Inc.; Aptalis Pharmatech, Inc.; Aptalis Pharma Canada Inc. [read post]
5 Oct 2020, 1:15 pm
In GlaxoSmithKline LLC v. [read post]
18 Oct 2008, 8:19 am
In the Hatch-Waxman area, Pozen, Inc. announced Par Pharmaceutical Inc. has filed an application with the Food and Drug Administration [FDA] to make a generic version of Treximet, a migraine treatment Pozen developed with GlaxoSmithKline PLC, and shares of Pozen shed nearly 28 percent of their value on 17 Oct. 08 [read post]
17 Jul 2015, 12:50 pm
In more detail, the Pliva, Inc., et al. v. [read post]
9 Aug 2010, 3:30 am
[GlaxoSmithKline Inc. v. [read post]
18 Jun 2007, 10:04 am
GlaxoSmithKline faces investor class action over misrepresentations about safety of diabetes drug Avandia Shareholder class action filed against biopharmaceutical corporation Telik, Inc. [read post]
26 Feb 2014, 5:37 pm
Procedural HistoryPlaintiff GlaxoSmithKline LLC (“GSK”) sued Banner Pharmacaps, Inc., Impax Laboratories, Inc., Roxane Laboratories, Inc., Mylan Inc., Mylan Pharmaceuticals, Inc., and Watson Laboratories, Inc. [read post]
20 Jul 2017, 8:17 am
Emergent BioSolutions Inc. has plans to acquire another medication that is stockpiled by the federal government for emergencies, and to begin making it in Baltimore in 2020. [read post]
11 Mar 2014, 10:00 pm
In GlaxoSmithKline LLC v. [read post]
23 Apr 2013, 1:00 am
In Biogen Idec, Inc. v. [read post]
25 Jun 2021, 4:15 am
A group of intellectual property professors; GlaxoSmithKline plc; and Biogen Inc., Bristol-Myers Squibb Company, Corning Incorporated, and Merck Sharp & Dohme Corp. filed amicus briefs. [read post]
24 Apr 2011, 8:43 pm
Glaxo Group Ltd. et al. 2:11-cv-03065; filed April 12, 2011 in the Central District of California • Plaintiffs: Genentech, Inc.; City of Hope • Defendants: Glaxo Group Ltd.; GlaxoSmithKline LLC; Human Genome Sciences, Inc.; Lonza Biologics PLC; Lonza Biologics Inc. [read post]
10 Feb 2008, 7:26 pm
SB Pharmco Puerto Rico, Inc. d/b/a GlaxoSmithKline et al. v. [read post]
8 Apr 2012, 8:51 pm
• Defendants: Glaxosmithkline PLC; Stiefel Laboratories, Inc. [read post]
20 May 2009, 8:55 pm
By Donald Zuhn -- In a Wednesday Super Session entitled "A Model Patent Office for the Future -- Promoting and Protecting Investments in Innovation," a panel consisting of Sherry Knowles, Vice President of Corporate Intellectual Property at GlaxoSmithKline Biopharmaceuticals, Inc.; Q. [read post]
5 Oct 2020, 1:15 pm
In GlaxoSmithKline LLC v. [read post]
16 Nov 2012, 11:58 am
GlaxoSmithKline LLC v. [read post]
